Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Metrics Appoints EVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Metrics Appoints EVP

Ross brings 20 years of managerial experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

John S. Ross has been appointed executive vice president at Metrics, Inc. Mr. Ross is responsible for managing and expanding the company’s contract service operations, including pharmaceutical oral dose formulation development with dedicated suites for potent product handling, clinical trial materials manufacturing, analytical testing method development and validation, stability studies, and other lab support services.
 
Mr. Ross has 20 years of managerial experience, including serving as chief operating officer and leading U.S. and Canadian operations at CPL, a CMO for liquid and semi-solid pharmaceutical products, headquartered in Canada.
 
“John has a proven track record of delivering strong business performance while ensuring operational excellence and quality compliance with regulatory agencies worldwide,” said Stefan Cross, president of Mayne Pharma USA. Metrics is owned by Mayne Pharma in Australia. “Metrics has, quite rightfully, earned a positive reputation for its thoughtful science and strong client relationships. John will help strengthen those partnerships to the benefit of all involved.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics